BridgeBio Pharma, Inc.
BBIO
40 insider filings · Latest: Jul 30, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | May 19 8:30 PM | Thomas TrimarchiPresident and CFO | Sale | 13,651 | $65.08 | $888.4K | 359,194(D) | View → |
| May 15, 2026 | May 19 8:25 PM | Randal W. ScottDirector | Sale | 10,000 | $67.15 | $671.5K | 11,589(D) | View → |
| May 18, 2026 | May 18 8:24 PM | THOMAS TRIMARCHI | Proposed Sale | 13,651 | $65.08 | $888.4K | — | View → |
| May 8, 2026 | May 11 9:15 PM | Neil KumarDirector, Chief Executive Officer | Sale | 40,000 | $66.91 | $2.7M | 4,358,447(I) | View → |
| May 7, 2026 | May 11 9:15 PM | Neil KumarDirector, Chief Executive Officer | Sale | 40,000 | $67.90 | $2.7M | 4,378,447(I) | View → |
| Apr 30, 2026 | May 4 8:22 PM | Maricel ApuliChief Accounting Officer | Sale | 2,000 | $71.58 | $143.2K | 134,115(D) | View → |
| Apr 10, 2026 | Apr 13 10:06 PM | Neil KumarDirector, Chief Executive Officer | Sale | 40,000 | $74.60 | $3.0M | 4,398,447(I) | View → |
| Apr 9, 2026 | Apr 13 10:06 PM | Neil KumarDirector, Chief Executive Officer | Sale | 40,000 | $74.62 | $3.0M | 4,418,447(I) | View → |
| Apr 9, 2026 | Apr 9 8:23 PM | KUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018 | Proposed Sale | 120,000 | $74.14 | $8.9M | — | View → |
| Mar 13, 2026 | Mar 16 10:05 PM | Neil KumarDirector, Chief Executive Officer | Sale | 40,000 | $68.80 | $2.8M | 4,438,447(I) | View → |
| Mar 12, 2026 | Mar 16 10:05 PM | Neil KumarDirector, Chief Executive Officer | Sale | 40,000 | $68.73 | $2.7M | 4,458,447(I) | View → |
| Mar 13, 2026 | Mar 13 8:22 PM | KUMAR HALDEA FAMILY IRREVOCABLE TRUST | Proposed Sale | 140,000 | $67.98 | $9.5M | — | View → |
| Mar 10, 2026 | Mar 12 8:15 PM | Hannah ValantineDirector | Sale | 8,671 | $72.00 | $624.3K | 7,465(D) | View → |
| Mar 10, 2026 | Mar 10 8:02 PM | HANNAH A VALANTINE | Proposed Sale | 8,671 | $72.00 | $624.3K | — | View → |
| Mar 4, 2026 | Mar 6 9:57 PM | Andrea EllisDirector | Sale | 64,921 | $64.87 | $4.2M | 18,589(D) | View → |
| Mar 4, 2026 | Mar 4 9:17 PM | ANDREA ELLIS | Proposed Sale | 64,921 | $64.87 | $4.2M | — | View → |
| Feb 27, 2026 | Mar 3 9:17 PM | Hannah ValantineDirector | Sale | 25,484 | $67.41 | $1.7M | 7,465(D) | View → |
| Feb 27, 2026 | Feb 27 9:20 PM | HANNAH A VALANTINE | Proposed Sale | 25,484 | $67.41 | $1.7M | — | View → |
| Feb 26, 2026 | Feb 27 9:11 PM | Maricel ApuliChief Accounting Officer | Sale | 2,000 | $66.00 | $132.0K | 121,945(D) | View → |
| Feb 19, 2026 | Feb 23 9:32 PM | Neil KumarDirector, Chief Executive Officer | Sale | 28,053 | $71.39 | $2.0M | 234,451(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Mar 12 8:15 PM | Hannah ValantineDirector | Option Exercise | 8,671 | $27.36 | 17,343(D) | View → |
| Mar 4, 2026 | Mar 6 9:57 PM | Andrea EllisDirector | Option Exercise | 64,921 | $8.45 | 0(D) | View → |
| Feb 27, 2026 | Mar 3 9:17 PM | Hannah ValantineDirector | Option Exercise | 25,484 | $48.45 | 0(D) | View → |
| Feb 16, 2026 | Feb 18 11:41 PM | Neil KumarDirector, Chief Executive Officer | Option Exercise | 64,698 | — | 138,645(D) | View → |
| Feb 17, 2026 | Feb 18 11:34 PM | Randal W. ScottDirector | Option Exercise | 10,000 | $16.75 | 31,501(D) | View → |
← Previous
Page 2 of 2